nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.0695	0.123	CcSEcCtD
Vinorelbine—Recall phenomenon—Dactinomycin—ocular cancer	0.0657	0.117	CcSEcCtD
Vinorelbine—Neutropenic sepsis—Dactinomycin—ocular cancer	0.0657	0.117	CcSEcCtD
Vinorelbine—Extravasation—Carboplatin—ocular cancer	0.0352	0.0624	CcSEcCtD
Vinorelbine—Phlebitis—Carboplatin—ocular cancer	0.0259	0.0459	CcSEcCtD
Vinorelbine—Myelosuppression—Dactinomycin—ocular cancer	0.0243	0.0431	CcSEcCtD
Vinorelbine—Febrile neutropenia—Dactinomycin—ocular cancer	0.019	0.0336	CcSEcCtD
Vinorelbine—Necrosis—Dactinomycin—ocular cancer	0.0145	0.0257	CcSEcCtD
Vinorelbine—Extravasation—Dactinomycin—ocular cancer	0.0131	0.0232	CcSEcCtD
Vinorelbine—Infection—Carboplatin—ocular cancer	0.0109	0.0193	CcSEcCtD
Vinorelbine—Aplastic anaemia—Dactinomycin—ocular cancer	0.0107	0.019	CcSEcCtD
Vinorelbine—Oesophagitis—Dactinomycin—ocular cancer	0.0104	0.0185	CcSEcCtD
Vinorelbine—Sepsis—Dactinomycin—ocular cancer	0.00989	0.0175	CcSEcCtD
Vinorelbine—Phlebitis—Dactinomycin—ocular cancer	0.00961	0.017	CcSEcCtD
Vinorelbine—Pain—Carboplatin—ocular cancer	0.00937	0.0166	CcSEcCtD
Vinorelbine—Hepatic failure—Dactinomycin—ocular cancer	0.00921	0.0163	CcSEcCtD
Vinorelbine—TUBB—G2/M Transition—MYBL2—ocular cancer	0.00868	0.0199	CbGpPWpGaD
Vinorelbine—Body temperature increased—Carboplatin—ocular cancer	0.00866	0.0154	CcSEcCtD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—MYBL2—ocular cancer	0.00856	0.0196	CbGpPWpGaD
Vinorelbine—Lethargy—Dactinomycin—ocular cancer	0.00845	0.015	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.00745	0.0132	CcSEcCtD
Vinorelbine—TUBB—G2/M Transition—RBBP4—ocular cancer	0.00738	0.0169	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—RBBP4—ocular cancer	0.00728	0.0167	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—E2F3—ocular cancer	0.00728	0.0167	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—MYBL2—ocular cancer	0.0072	0.0165	CbGpPWpGaD
Vinorelbine—Dysphagia—Dactinomycin—ocular cancer	0.00715	0.0127	CcSEcCtD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—MYBL2—ocular cancer	0.0071	0.0163	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—CDC25A—ocular cancer	0.00702	0.0161	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—CDC25A—ocular cancer	0.00693	0.0159	CbGpPWpGaD
Vinorelbine—Pancytopenia—Dactinomycin—ocular cancer	0.00679	0.012	CcSEcCtD
Vinorelbine—Neutropenia—Dactinomycin—ocular cancer	0.00669	0.0119	CcSEcCtD
Vinorelbine—TUBB4B—G2/M Transition—MYBL2—ocular cancer	0.00658	0.0151	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—MYBL2—ocular cancer	0.00649	0.0149	CbGpPWpGaD
Vinorelbine—Pneumonia—Dactinomycin—ocular cancer	0.00642	0.0114	CcSEcCtD
Vinorelbine—Stomatitis—Dactinomycin—ocular cancer	0.00622	0.011	CcSEcCtD
Vinorelbine—TUBB4A—G2/M Transition—RBBP4—ocular cancer	0.00612	0.014	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—RBBP4—ocular cancer	0.00603	0.0138	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—E2F3—ocular cancer	0.00603	0.0138	CbGpPWpGaD
Vinorelbine—Agranulocytosis—Dactinomycin—ocular cancer	0.00595	0.0105	CcSEcCtD
Vinorelbine—TUBB4A—G2/M Transition—CDC25A—ocular cancer	0.00582	0.0134	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—CDC25A—ocular cancer	0.00574	0.0132	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—RBBP4—ocular cancer	0.0056	0.0128	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—RBBP4—ocular cancer	0.00552	0.0127	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—E2F3—ocular cancer	0.00552	0.0127	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—CDC25A—ocular cancer	0.00532	0.0122	CbGpPWpGaD
Vinorelbine—Flushing—Dactinomycin—ocular cancer	0.00531	0.00942	CcSEcCtD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—CDC25A—ocular cancer	0.00525	0.012	CbGpPWpGaD
Vinorelbine—Alopecia—Dactinomycin—ocular cancer	0.00506	0.00897	CcSEcCtD
Vinorelbine—Erythema—Dactinomycin—ocular cancer	0.00498	0.00883	CcSEcCtD
Vinorelbine—Ill-defined disorder—Dactinomycin—ocular cancer	0.00462	0.0082	CcSEcCtD
Vinorelbine—Anaemia—Dactinomycin—ocular cancer	0.00461	0.00817	CcSEcCtD
Vinorelbine—Malaise—Dactinomycin—ocular cancer	0.00449	0.00797	CcSEcCtD
Vinorelbine—Leukopenia—Dactinomycin—ocular cancer	0.00446	0.00791	CcSEcCtD
Vinorelbine—Myalgia—Dactinomycin—ocular cancer	0.00424	0.00752	CcSEcCtD
Vinorelbine—Discomfort—Dactinomycin—ocular cancer	0.00419	0.00743	CcSEcCtD
Vinorelbine—Infection—Dactinomycin—ocular cancer	0.00404	0.00716	CcSEcCtD
Vinorelbine—Thrombocytopenia—Dactinomycin—ocular cancer	0.00398	0.00706	CcSEcCtD
Vinorelbine—Anorexia—Dactinomycin—ocular cancer	0.00388	0.00687	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.00371	0.00657	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—CDKN1A—ocular cancer	0.00369	0.00847	CbGpPWpGaD
Vinorelbine—Decreased appetite—Dactinomycin—ocular cancer	0.00354	0.00627	CcSEcCtD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—EP300—ocular cancer	0.00351	0.00806	CbGpPWpGaD
Vinorelbine—Fatigue—Dactinomycin—ocular cancer	0.00351	0.00622	CcSEcCtD
Vinorelbine—Pain—Dactinomycin—ocular cancer	0.00348	0.00617	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00339	0.00778	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00336	0.00772	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Dactinomycin—ocular cancer	0.00335	0.00594	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dactinomycin—ocular cancer	0.00333	0.0059	CcSEcCtD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—E2F1—ocular cancer	0.00323	0.00742	CbGpPWpGaD
Vinorelbine—Body temperature increased—Dactinomycin—ocular cancer	0.00322	0.0057	CcSEcCtD
Vinorelbine—Abdominal pain—Dactinomycin—ocular cancer	0.00322	0.0057	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CDKN2C—ocular cancer	0.00303	0.00695	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Dactinomycin—ocular cancer	0.003	0.00531	CcSEcCtD
Vinorelbine—Asthenia—Dactinomycin—ocular cancer	0.00292	0.00517	CcSEcCtD
Vinorelbine—TUBB—G2/M Transition—CDK2—ocular cancer	0.00283	0.00649	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00282	0.00647	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00281	0.00644	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.0028	0.00642	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—CDK2—ocular cancer	0.00279	0.0064	CbGpPWpGaD
Vinorelbine—Diarrhoea—Dactinomycin—ocular cancer	0.00278	0.00493	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00276	0.00634	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00276	0.00634	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00271	0.00622	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00271	0.00622	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—E2F1—ocular cancer	0.00268	0.00615	CbGpPWpGaD
Vinorelbine—Vomiting—Dactinomycin—ocular cancer	0.00259	0.00458	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2C—ocular cancer	0.00257	0.00589	CbGpPWpGaD
Vinorelbine—Rash—Dactinomycin—ocular cancer	0.00256	0.00455	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—EIF1AX—ocular cancer	0.00255	0.00585	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—EIF1AX—ocular cancer	0.00255	0.00585	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—E2F5—ocular cancer	0.00252	0.00579	CbGpPWpGaD
Vinorelbine—TUBB2A—Signaling events mediated by HDAC Class III—TP53—ocular cancer	0.00251	0.00577	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2C—ocular cancer	0.00251	0.00576	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00249	0.00571	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—E2F4—ocular cancer	0.00247	0.00567	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYBL2—ocular cancer	0.00247	0.00567	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—EIF1AX—ocular cancer	0.00246	0.00565	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—E2F1—ocular cancer	0.00245	0.00563	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RBL1—ocular cancer	0.00242	0.00556	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—E2F2—ocular cancer	0.00242	0.00556	CbGpPWpGaD
Vinorelbine—Nausea—Dactinomycin—ocular cancer	0.00242	0.00428	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—EIF1AX—ocular cancer	0.00238	0.00547	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00235	0.00539	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00235	0.00539	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—CDK2—ocular cancer	0.00234	0.00538	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00234	0.00536	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—EIF1AX—ocular cancer	0.00233	0.00535	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—CDK2—ocular cancer	0.00231	0.00531	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2C—ocular cancer	0.0023	0.00527	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00229	0.00525	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00229	0.00525	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00224	0.00515	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00224	0.00515	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00223	0.00513	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RBL2—ocular cancer	0.00222	0.0051	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00218	0.00501	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—CDK2—ocular cancer	0.00214	0.00492	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—E2F5—ocular cancer	0.00214	0.0049	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—CDK2—ocular cancer	0.00211	0.00485	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—E2F3—ocular cancer	0.0021	0.00482	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RBBP4—ocular cancer	0.0021	0.00482	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—E2F4—ocular cancer	0.00209	0.0048	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYBL2—ocular cancer	0.00209	0.0048	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—EIF1AX—ocular cancer	0.00209	0.0048	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—E2F5—ocular cancer	0.00209	0.00479	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.00208	0.00478	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00206	0.00473	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—E2F2—ocular cancer	0.00205	0.00471	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RBL1—ocular cancer	0.00205	0.00471	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—E2F4—ocular cancer	0.00205	0.0047	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYBL2—ocular cancer	0.00205	0.0047	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—RPL39—ocular cancer	0.00204	0.00468	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—RPL39—ocular cancer	0.00204	0.00468	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—E2F2—ocular cancer	0.00201	0.00461	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RBL1—ocular cancer	0.00201	0.00461	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDC25A—ocular cancer	0.002	0.00458	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00198	0.00454	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—RPL39—ocular cancer	0.00197	0.00452	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TFDP1—ocular cancer	0.00195	0.00448	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00195	0.00447	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00195	0.00447	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—EIF1AX—ocular cancer	0.00191	0.00439	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—E2F5—ocular cancer	0.00191	0.00438	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—RPL39—ocular cancer	0.00191	0.00437	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RBL2—ocular cancer	0.00188	0.00433	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYBL2—ocular cancer	0.00187	0.0043	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—E2F4—ocular cancer	0.00187	0.0043	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—RPL39—ocular cancer	0.00186	0.00428	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00185	0.00425	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RBL2—ocular cancer	0.00184	0.00423	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—E2F2—ocular cancer	0.00184	0.00421	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RBL1—ocular cancer	0.00184	0.00421	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00181	0.00415	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—E2F3—ocular cancer	0.00178	0.00408	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RBBP4—ocular cancer	0.00178	0.00408	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND3—ocular cancer	0.00177	0.00406	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—E2F3—ocular cancer	0.00174	0.00399	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RBBP4—ocular cancer	0.00174	0.00399	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDC25A—ocular cancer	0.00169	0.00389	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RBL2—ocular cancer	0.00169	0.00387	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—RPL39—ocular cancer	0.00167	0.00384	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDC25A—ocular cancer	0.00166	0.0038	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TFDP1—ocular cancer	0.00165	0.0038	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND3—ocular cancer	0.00164	0.00376	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TFDP1—ocular cancer	0.00162	0.00371	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RBBP4—ocular cancer	0.00159	0.00365	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—E2F3—ocular cancer	0.00159	0.00365	CbGpPWpGaD
Vinorelbine—TUBB—G2/M Transition—EP300—ocular cancer	0.00159	0.00365	CbGpPWpGaD
Vinorelbine—TUBB—Mitotic G2-G2/M phases—EP300—ocular cancer	0.00157	0.0036	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—RPL39—ocular cancer	0.00153	0.00351	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDC25A—ocular cancer	0.00151	0.00347	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND3—ocular cancer	0.0015	0.00344	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TFDP1—ocular cancer	0.00148	0.0034	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00148	0.00338	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND3—ocular cancer	0.00147	0.00337	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND3—ocular cancer	0.00134	0.00308	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK6—ocular cancer	0.00132	0.00303	CbGpPWpGaD
Vinorelbine—TUBB4A—G2/M Transition—EP300—ocular cancer	0.00132	0.00302	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00131	0.00302	CbGpPWpGaD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—EP300—ocular cancer	0.0013	0.00298	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00129	0.00296	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00127	0.00291	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00127	0.00291	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00122	0.0028	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—EP300—ocular cancer	0.0012	0.00276	CbGpPWpGaD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—EP300—ocular cancer	0.00119	0.00273	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.00114	0.00261	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND2—ocular cancer	0.00113	0.0026	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—HDAC1—ocular cancer	0.00113	0.0026	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK6—ocular cancer	0.00112	0.00257	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK6—ocular cancer	0.00109	0.00251	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND2—ocular cancer	0.00105	0.00241	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.00105	0.00241	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—E2F1—ocular cancer	0.00104	0.00239	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN2B—ocular cancer	0.00102	0.00233	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK6—ocular cancer	0.001	0.00229	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND2—ocular cancer	0.000961	0.00221	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—HDAC1—ocular cancer	0.000961	0.00221	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000942	0.00216	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND2—ocular cancer	0.00094	0.00216	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—HDAC1—ocular cancer	0.00094	0.00216	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—E2F1—ocular cancer	0.000933	0.00214	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK2—ocular cancer	0.0009	0.00207	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000865	0.00198	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000862	0.00198	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND2—ocular cancer	0.00086	0.00197	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—HDAC1—ocular cancer	0.00086	0.00197	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000851	0.00195	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2B—ocular cancer	0.000842	0.00193	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000813	0.00187	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK2—ocular cancer	0.000805	0.00185	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000791	0.00181	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—E2F1—ocular cancer	0.000773	0.00177	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2B—ocular cancer	0.00077	0.00177	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK4—ocular cancer	0.000761	0.00175	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000746	0.00171	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RB1—ocular cancer	0.00074	0.0017	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—E2F1—ocular cancer	0.000707	0.00162	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000705	0.00162	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000682	0.00157	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK2—ocular cancer	0.000667	0.00153	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—RB1—ocular cancer	0.000661	0.00152	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000645	0.00148	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK4—ocular cancer	0.00063	0.00145	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000622	0.00143	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RB1—ocular cancer	0.000613	0.00141	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK2—ocular cancer	0.00061	0.0014	CbGpPWpGaD
Vinorelbine—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000577	0.00132	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK4—ocular cancer	0.000576	0.00132	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000576	0.00132	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MDM2—ocular cancer	0.000564	0.00129	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000563	0.00129	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RB1—ocular cancer	0.000561	0.00129	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000549	0.00126	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RB1—ocular cancer	0.000548	0.00126	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000541	0.00124	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000531	0.00122	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1B—ocular cancer	0.000515	0.00118	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—EP300—ocular cancer	0.000506	0.00116	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RB1—ocular cancer	0.000501	0.00115	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000496	0.00114	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—ocular cancer	0.000491	0.00113	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000477	0.00109	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1A—ocular cancer	0.000475	0.00109	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MDM2—ocular cancer	0.000467	0.00107	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000455	0.00104	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—EP300—ocular cancer	0.000452	0.00104	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—ocular cancer	0.000441	0.00101	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.00044	0.00101	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000436	0.001	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000428	0.000983	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MDM2—ocular cancer	0.000427	0.000981	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—ocular cancer	0.000427	0.000979	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSPH—ocular cancer	0.000426	0.000976	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000424	0.000972	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—EP300—ocular cancer	0.000419	0.000962	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000416	0.000955	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—ocular cancer	0.000407	0.000934	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000405	0.000929	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000403	0.000924	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSPH—ocular cancer	0.000401	0.00092	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—ocular cancer	0.000394	0.000904	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1A—ocular cancer	0.000394	0.000904	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—ocular cancer	0.00039	0.000895	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—EP300—ocular cancer	0.000383	0.000879	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—EP300—ocular cancer	0.000375	0.00086	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—ocular cancer	0.000372	0.000854	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—ocular cancer	0.000365	0.000838	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1A—ocular cancer	0.00036	0.000826	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—EP300—ocular cancer	0.000343	0.000786	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.00034	0.000781	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—ocular cancer	0.000334	0.000766	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—ocular cancer	0.000326	0.000749	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—ocular cancer	0.000324	0.000743	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.0003	0.000689	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—ocular cancer	0.000299	0.000685	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000274	0.000629	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—ocular cancer	0.000268	0.000615	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSPH—ocular cancer	0.000262	0.000602	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000261	0.0006	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000253	0.00058	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—ocular cancer	0.000245	0.000563	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000241	0.000552	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00021	0.000481	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000209	0.00048	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000172	0.000395	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000145	0.000334	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GNA11—ocular cancer	0.000134	0.000307	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GNA11—ocular cancer	0.000126	0.00029	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GNAQ—ocular cancer	0.000124	0.000286	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000117	0.000269	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GNA11—ocular cancer	8.25e-05	0.000189	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GNAQ—ocular cancer	7.67e-05	0.000176	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EP300—ocular cancer	4.47e-05	0.000103	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EP300—ocular cancer	4.22e-05	9.67e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EP300—ocular cancer	2.76e-05	6.32e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—AKT1—ocular cancer	2.7e-05	6.2e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—AKT1—ocular cancer	2.55e-05	5.85e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—AKT1—ocular cancer	1.67e-05	3.82e-05	CbGpPWpGaD
